|

Allogenic NK cells infusion Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Marzieh Ebrahimi1

Indications

  • Neuroblastoma in Children1
  • Neuroblastoma, Recurrent, Refractory1
  • Neuroblastoma (NB)1
  • Cancer1

Other1 trial

Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.